| Abbreviation | Extended (English) |
| ACTH | Adrenocorticotropic Hormone |
| CBT-I | Cognitive Behavioral Therapy for Insomnia |
| CNS | Central Nervous System |
| CRP | C-Reactive Protein |
| DORA | Dual orexin receptor antagonist |
| EEG | Electroencephalogram |
| FDA | Food and Drug Administration |
| GnRH | Gonadotropin-Releasing Hormone |
| ICSD-3 | International Classification of Sleep Disorders, Third Edition |
| IL-6, IL-12 | Interleukin 6, Interleukin 12 |
| ISI | Insomnia Severity Index |
| HPA | Hypothalamic–Pituitary–Adrenal Axis |
| MHT | Menopausal Hormone Therapy |
| KNDy | Kisspeptin, Neurokinin B, Dynorphin Neurons |
| MBT | Mindfulness-Based Therapy |
| NCCN | National Comprehensive Cancer Network |
| NCI | National Cancer Institute (NCI) |
| NKB | Neurokinin B |
| NKR | Neurokin receptor |
| NK1-3R, NK3R | Neurokinin 1-3 receptor, Neurokinin 3 receptor |
| NREM | Non-Rapid Eye Movement |
| PLMD | Periodic Limb Movement Disorder |
| PSG | Polysomnography |
| PSQI | Pittsburgh Sleep Quality Index |
| REM | Rapid Eye Movement |
| REMS | REM Sleep |
| SCI | Sleep condition indicator |
| SNRI | Serotonin-Norepinephrine Reuptake Inhibitor |
| SP | Substance P |
| SSRI | Selective Serotonin Reuptake Inhibitor |
| SWA | Slow-Wave Activity |
| TNF | Tumor Necrosis Factor |
| VLPO | Ventrolateral Preoptic Nucleus |
| U.S. | United States |
| VMS | Vasomotor Symptom |